Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy

Gastroenterology
K E ObergEric P Krenning

Abstract

The incidence and prevalence of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) have increased in the past 20 years. GEP-NETs are heterogeneous tumors, in terms of clinical and biological features, that originate from the pancreas or the intestinal tract. Some GEP-NETs grow very slowly, some grow rapidly and do not cause symptoms, and others cause hormone hypersecretion and associated symptoms. Most GEP-NETs overexpress receptors for somatostatins. Somatostatins inhibit the release of many hormones and other secretory proteins; their effects are mediated by G protein-coupled receptors that are expressed in a tissue-specific manner. Most GEP-NETs overexpress the somatostatin receptor SSTR2; somatostatin analogues are the best therapeutic option for functional neuroendocrine tumors because they reduce hormone-related symptoms and also have antitumor effects. Long-acting formulations of somatostatin analogues stabilize tumor growth over long periods. The development of radioactive analogues for imaging and peptide receptor radiotherapy has improved the management of GEP-NETs. Peptide receptor radiotherapy has significant antitumor effects, increasing overall survival times of patients with tumors that express a high densit...Continue Reading

References

Sep 11, 1986·The New England Journal of Medicine·L K KvolsR G Hahn
Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R Z CaiA V Schally
Dec 1, 1984·The Journal of Clinical Endocrinology and Metabolism·J C Reubi, A M Landolt
Jan 1, 1997·The Journal of Clinical Endocrinology and Metabolism·P CaronP Jaquet
Apr 16, 1998·International Journal of Cancer. Journal International Du Cancer·K Sharma, C B Srikant
Jul 10, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B Eriksson, K Oberg
Nov 7, 1999·European Journal of Nuclear Medicine·A OtteJ Muller
Aug 24, 2000·American Journal of Clinical Oncology·S RicciP F Conte
Aug 23, 2001·British Journal of Anaesthesia·M A KinneyM A Warner
Apr 20, 2002·Seminars in Nuclear Medicine·Lowell B AnthonyKevin E McCarthy
Apr 20, 2002·Seminars in Nuclear Medicine·Marion De JongEric P Krenning
Sep 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jürgen DunstStefan Frings
Dec 19, 2002·Journal of Clinical Gastroenterology·Houssam Al Kharrat, Howard Taubin
Jan 29, 2003·European Journal of Nuclear Medicine and Molecular Imaging·Lisa BodeiGiovanni Paganelli
Feb 18, 2003·Endocrine Reviews·Leo J Hofland, Steven W J Lamberts
Apr 23, 2003·European Journal of Nuclear Medicine and Molecular Imaging·Jean Claude Reubi, Beatrice Waser
Aug 16, 2003·Endocrine Reviews·Jean Claude Reubi
Sep 25, 2003·Cancer Biotherapy & Radiopharmaceuticals·Eugene A Woltering
Dec 5, 2003·Nature Reviews. Drug Discovery·Gisbert WeckbeckerChristian Bruns
May 19, 2004·Journal of Neurochemistry·Gisela OliasWolfgang Meyerhof
May 21, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K ObergB Wiedenmann
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tyvin A RichStephen T Mosley
Jul 14, 2004·European Journal of Endocrinology·Staffan V WelinBarbro K Eriksson
Jan 12, 2005·The Journal of Endocrinology·Roger Guillemin
Apr 28, 2005·Molecular Pharmacology·Qisheng LiuAgnes Schonbrunn
Jun 8, 2006·Digestive Diseases and Sciences·Thomas E ClancyMatthew H Kulke
Aug 26, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Luis de Lecea, Justo P Castaño
Oct 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Mihaela GinjJean Claude Reubi
May 24, 2007·European Journal of Nuclear Medicine and Molecular Imaging·I BuchmannU Haberkorn
Sep 18, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Marco VolanteMauro Papotti
Jan 23, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Bart de KeizerDik J Kwekkeboom
Mar 25, 2008·Molecular and Cellular Endocrinology·Stéphane PyronnetChristiane Susini
Apr 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mihaela GinjHelmut R Maecke

❮ Previous
Next ❯

Citations

Aug 14, 2012·Journal of Gastroenterology·Tetsuhide ItoRobert T Jensen
Jan 21, 2012·Neuroendocrinology·Robert T JensenUNKNOWN Barcelona Consensus Conference participants
Jun 28, 2012·Endocrine-related Cancer·Jennifer A ChanMatthew H Kulke
Jan 8, 2014·Theranostics·Irina Velikyan
Mar 12, 2013·International Journal of Peptides·Federica BarbieriTullio Florio
Sep 29, 2015·Expert Review of Gastroenterology & Hepatology·Antonio PeaLaura D Wood
Dec 5, 2015·Expert Opinion on Pharmacotherapy·Muhammad Wasif Saif
Jul 26, 2014·Expert Opinion on Investigational Drugs·Andrea GiustinaAlfredo Berruti
Mar 15, 2016·Best Practice & Research. Clinical Endocrinology & Metabolism·Meike Körner
Jan 29, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Clément MorgatAntoine Tabarin
Jul 23, 2013·Frontiers in Neuroendocrinology·Marily Theodoropoulou, Günter K Stalla
Feb 3, 2016·International Journal of Endocrine Oncology·Tetsuhide Ito, Robert T Jensen
Mar 19, 2013·Regulatory Peptides·Kukka Heiskala, Leif C Andersson
Feb 9, 2013·Seminars in Oncology·David Leung, Lawrence Schwartz
Nov 26, 2010·Gastroenterology Clinics of North America·Matthias MiedererChristian Fottner
Nov 29, 2015·Hematology/oncology Clinics of North America·Nitya Raj, Diane Reidy-Lagunes
Oct 24, 2013·The Prostate·Meike KörnerJean Claude Reubi
Dec 3, 2014·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Chieko SugawaraYouji Miyamoto
Feb 18, 2015·Journal of Hepato-biliary-pancreatic Sciences·Hisato IgarashiTetsuhide Ito
Dec 7, 2014·Cancer Chemotherapy and Pharmacology·Daniel CastellanoEric Raymond
Sep 18, 2016·Journal of Gastroenterology and Hepatology·Shigeru HoriguchiHiroyuki Okada
Feb 2, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·L de la CuevaD Abós
Nov 17, 2017·Current Treatment Options in Oncology·Inbal UriSimona Grozinsky-Glasberg
May 22, 2018·Anti-cancer Drugs·Limin GaoMuhammad W Saif
Nov 29, 2014·European Journal of Endocrinology·T Alonso-GordoaE Grande
Apr 22, 2016·Molecular Endocrinology·Andreas LehmannStefan Schulz
Feb 19, 2011·Molecular Endocrinology·Falko NagelStefan Schulz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.